Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence

被引:62
作者
Rizk, Mina
Monaghan, Madeline
Shorr, Risa
Kekre, Natasha
Bredeson, Christopher N.
Allan, David S.
机构
[1] Ottawa Hosp, Dept Med, Blood & Marrow Transplantat, Ottawa, ON, Canada
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
关键词
Mesenchymal stromal cell; Graft-versus-host disease; Hematopoietic cell transplantation; Systematic review; Treatment; Prevention; STEROID-REFRACTORY ACUTE; CONSENSUS DEVELOPMENT PROJECT; HEMATOPOIETIC STEM-CELLS; PHASE-III TRIAL; ACUTE GVHD; LYMPHOCYTE-PROLIFERATION; PEDIATRIC-PATIENTS; UNRELATED DONORS; CLINICAL-TRIALS; OPEN-LABEL;
D O I
10.1016/j.bbmt.2016.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effective treatments are lacking for the treatment of steroid-refractory graft-versus-host disease (GVHD), a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation. Mesenchymal stromal cells (MSCs) have demonstrated promise but there is uncertainty regarding their clinical effectiveness. A systematic scoping review of the literature was performed to characterize the heterogeneity of published studies and identify opportunities for standardization. Thirty studies were identified, including 19 studies (507 patients) addressing the treatment of acute or chronic GVHD and 11 prevention studies (277 patients). Significant heterogeneity was observed in the age and diagnoses of study subjects, intensity and specifics of the conditioning regimens, degree of HLA matching, and source of hematopoietic cells. MSCs were derived from bone marrow (83% of studies), cord blood (13%), or adipose tissue (3%) and were cryopreserved from third-party allogeneic donors in the majority of studies (91% of prevention studies and 63% of treatment studies). Culture conditions and media supplements were highly variable and characterization of MSCs did not conform to all International Society for Cellular Therapy criteria in any study. MSCs were harvested from cell culture at passage 1 to 7 and the dosage of MSCs ranged from 0.3 to 10 x 10(6)/kg, using varying schedules of administration. Treatment response criteria were not standardized and effectiveness in controlled treatment studies (5 studies) was unconvincing. Details of actively recruiting trials suggest heterogeneity still persists with only 53% of registered trials describing the use of standard GVHD response criteria and few detailing methods of MSC manufacturing. Future studies will need to make substantial coordinated efforts to reduce study heterogeneity and clarify the role of MSCs in GVHD. (C) 2016 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1416 / 1423
页数:8
相关论文
共 62 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis [J].
Akiyama, Kentaro ;
Chen, Chider ;
Wang, DanDan ;
Xu, Xingtian ;
Qu, Cunye ;
Yamaza, Takayoshi ;
Cai, Tao ;
Chen, WanJun ;
Sun, Lingyun ;
Shi, Songtao .
CELL STEM CELL, 2012, 10 (05) :544-555
[3]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[4]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[5]   Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease [J].
Ball, Lynne M. ;
Bernardo, Maria E. ;
Roelofs, Helene ;
van Tol, Maarten J. D. ;
Contoli, Benedetta ;
Zwaginga, Jaap Jan ;
Avanzini, Maria Antonia ;
Conforti, Antonella ;
Bertaina, Alice ;
Giorgiani, Giovanna ;
Jol-van der Zijde, Cornelia M. ;
Zecca, Marco ;
Le Blanc, Katarina ;
Frassoni, Francesco ;
Egeler, Rudolph Maarten ;
Fibbe, Willem E. ;
Lankester, Arjan C. ;
Locatelli, Franco .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) :501-509
[6]   Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning [J].
Baron, Frederic ;
Lechanteur, Chantal ;
Willems, Evelyne ;
Bruck, France ;
Baudoux, Etienne ;
Seidel, Laurence ;
Vanbellinghen, Jean-Francois ;
Hafraoui, Kaoutar ;
Lejeune, Marie ;
Gothot, Andre ;
Fillet, Georges ;
Beguin, Yves .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) :838-847
[7]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[8]   Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation [J].
Bernardo, M. E. ;
Ball, L. M. ;
Cometa, A. M. ;
Roelofs, H. ;
Zecca, M. ;
Avanzini, M. A. ;
Bertaina, A. ;
Vinti, L. ;
Lankester, A. ;
Maccario, R. ;
Ringden, O. ;
Le Blanc, K. ;
Egeler, R. M. ;
Fibbe, W. E. ;
Locatelli, F. .
BONE MARROW TRANSPLANTATION, 2011, 46 (02) :200-207
[9]   Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis [J].
Chen, Xiaomei ;
Wang, Chunyan ;
Yin, Jin ;
Xu, Jinhuan ;
Wei, Jia ;
Zhang, Yicheng .
PLOS ONE, 2015, 10 (08)
[10]   Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity [J].
Copland, Ian B. ;
Qayed, Muna ;
Garcia, Marco A. ;
Galipeau, Jacques ;
Waller, Edmund K. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) :934-940